CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in Deutsche Bank 39th Annual Health Care Conference in Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Wednesday, May 7, 2014 at 3:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
